Job Detail

Req #: 1901676


Location: Boudry, Neuchatel, Switzerland


Job Category: Technical Development


Work Location: Route de Perreux 1 2017


Organization: Supply Chain


Employee Status: Full-time


Job Type: Regular

Come join Celgene for this unique opportunity to be part of the team building a leading edge Clinical and Commercial CAR T Platform that serves our patients with novel Celgene CAR T Therapies.

This position will be responsible for leading the day-to-day Patient Scheduling and Cell Logistics operations in Europe, including but not limited to the orchestration of patient treatments between Apheresis Centers, Manufacturing Sites and Logistics Providers used for Celgene Clinical and Commercial Chimeric Antigen Receptor (CAR) T-cell Therapies. 

What great looks like in this role
You will have both tactical and strategic responsibilities and be willing to roll up their sleeves to do whatever is required to achieve objectives. 

Objectives of this Role

The primary focus of the manager will be supervising a team of associates who are responsible for scheduling and monitoring patient treatment schedules for the manufacturing of Celgene’s Clinical and Commercial autologous cellular immunotherapy products.

Daily and Monthly Responsibilities

• Provide leadership and build an exceptional team to manage the patient scheduling system and process


• Support hiring, training, coaching, and onboarding activities related to patient scheduling, cell logistics and case management


• Develop and enhance the patient scheduling system and process in support of CAR T clinical and commercial operations in Europe


• Collaborate with manufacturing, supply chain, quality, sales operations, clinical operations, third-party logistics partners and external manufacturers in the creation and/or improvement of the supporting business processes. This includes defining cross-functional work flow, communication, service level agreements, and objectives


• Participate in the development and implementation of patient scheduling infrastructure to support clinical and commercial patient scheduling. This includes standard operation procedures and work instructions as it relates to patient scheduling, cell therapy manufacturing, and cell logistics


• Collaborate with other leaders across the organization and assist in the continuous improvement of the patient scheduling system and process


• Manage activities and project milestones to implement changes and improvements


• Demonstrated ability to work cross-functionally and to develop and maintain strong business partner relationships


• Proven ability to carry out difficult decisions in a logical, rational manner, and demonstrated ability to work as a senior management team member and to engage and influence team members

Knowledge and skills required ​

• Bachelor’s degree with 5+ years of scheduling or planning experience in a pharma/biotech or health services environment.


• Must be skilled in planning and organizing, conflict management, decision-making, building relationships, innovation management, and resource allocation


• Experience working in a regulated environment (cGMP/FDA)


• Experience in scheduling and/or planning is preferred


• Excellent leadership, communication and presentation skills 


• Ability to make decisions in a fast-paced, high-volume environment


• Highly self-motivated individual, with demonstrated ability to work independently


• Flexibility in responding to change or business needs


• Exceptional customer service orientation


• Ability to accommodate non-traditional work schedules


• Required written and verbal fluency in English language and minimally one other required European language (German, French, Spanish or Italian)

About Us




COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE



At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.




"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."



There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.